MCRB Dividend History & Analysis | N/A Yield

MCRB has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.

As of January 2026, Seres Therapeutics (MCRB) does not pay a dividend.

Top Dividend Payers in Biotechnology

Top 5 Dividend Yields of Peer-Group
Symbol Market Cap USD Dividend Yield TTM Yield on Cost 5y
ABBV 383,081 M 4.30% 7.26%
AMGN 177,715 M 3.21% 5.56%
GILD 154,989 M 2.79% 5.72%
HLN 43,773 M 1.76% 2.46%
BIM 14,355 M 0.74% 0.76%
Top 5 Dividend Growth Rates of Peer-Group
Symbol Market Cap USD Growth Rate Consistency
BTX 1,478 M 134% 95.6%
HLN 43,773 M 30.1% 100%
AMGN 177,715 M 7.84% 100%
BIM 14,355 M 9.76% 96.0%
ABBV 383,081 M 5.98% 100%

Quality Dividend Peers in Biotechnology

AMGN
Amgen
 3.21% Yield
GILD
Gilead Sciences
 2.79% Yield

MCRB Dividend History: as of January 2026

No dividends paid yet.

MCRB Dividend FAQ

Seres Therapeutics (NASDAQ:MCRB) is a clinical-stage biotech focused on live biotherapeutic products that modulate the gut microbiome to prevent infection-related complications in high-risk patients. Its lead candidate, SER-155, is an oral formulation intended to decolonize pathogenic bacteria and strengthen the intestinal barrier in recipients of allogeneic hematopoietic stem cell transplants, aiming to reduce bloodstream infections. The pipeline also includes SER-147 for metabolic-disease-related infections, and SER-287 and SER-301, both in Phase 2 trials for mild-to-moderate ulcerative colitis.

What is the Dividend Yield of MCRB?

As of January 2026, MCRB`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 15.06.

Does MCRB pay a dividend?

As of January 2026 MCRB does not pay a dividend.

How often does MCRB pay dividends?

Over the last 12 months, MCRB has issued dividend payments.

MCRB dividend forecast

Based on historical data, the forecasted dividends per share for MCRB for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).
This suggests the dividend will remain relatively stable.

Will MCRB pay dividends in 2026?

The next Ex-Dividend date for Seres Therapeutics (MCRB) is currently unknown.

What is the next Ex-Dividend Date for MCRB?

The next Ex-Dividend date for Seres Therapeutics (MCRB) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of MCRB?

MCRB's average dividend growth rate over the past 5 years is -% per year.

What is the Yield on Cost of MCRB?

MCRB's 5-Year Yield on Cost is -%. If you bought MCRB's shares at 481.00 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of MCRB?

MCRB Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.

Does MCRB have a good Dividend Yield?

MCRB`s % Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of MCRB?

The Dividend Payout Ratio of MCRB is unknown.

What is the Dividend Rating of MCRB?

MCRB`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

MCRB Outstanding Shares Analysis

What is the Trend in MCRB's Outstanding Shares?

Seres Therapeutics's outstanding shares have increased by approximately 16.5% annually over the past 3 years (Trend Reliability: 100.0%).

Significant dilution: Heavy share issuance is diluting existing shareholders. Even if total dividends paid increase, your dividend per share may stagnate or decline.

Has MCRB ever had a Stock Split?

Yes, the last stock split was on Apr 22, 2025 with a ratio of 1:20.

This was a reverse split: Multiple shares were consolidated into fewer shares, increasing the price per share. This is sometimes used to meet exchange listing requirements and can be a warning sign if the company is struggling.

Year Number of Shares Annual Growth Rate
2013 1,261,600
2014 1,699,300 +34.69%
2015 1,961,000 +15.4%
2016 2,018,400 +2.93%
2017 2,028,600 +0.51%
2018 2,046,800 +0.9%
2019 3,507,200 +71.35%
2020 4,573,000 +30.39%
2021 4,594,500 +0.47%
2022 6,261,100 +36.27%
2023 6,463,100 +3.23%
2024 8,650,400 +33.84%
2025 8,771,500 +1.4%

Key Metric Definitions

Dividend Yield
Annual dividend per share divided by current share price.
Payout Ratio
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Payout FCF
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Growth Rate (CAGR)
Compound annual growth rate of dividends over the last 5 years.
Consistency
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Yield on Cost
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Streak
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Dividend Rating
Proprietary score (0-100) combining yield, growth, safety and consistency.

Last update: 2026-01-14 02:43